CMV-specific immunotherapy

Human Immunology

Volumn 65, Issue 5, 2004, Pages 558-564

  Einsele, Hermann ^a   Hebart, Holger ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

adoptive immunotherapy; CMV; T Cells

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; THYMIDINE KINASE;

ACUTE TOXICITY; ADOPTIVE IMMUNOTHERAPY; ARTICLE; CELL POPULATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; GENE THERAPY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; SIDE EFFECT; T LYMPHOCYTE; VIREMIA;

ADOPTIVE TRANSFER; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE THERAPY; HUMANS; IMMUNOTHERAPY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TRANSPLANTATION;

EID: 2542457298     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2004.02.003     Document Type: Article

References (43)

1. Meyers J.D., Bowden R.A., Counts G.W. Infectious complications of marrow transplant risk factors for infection. Prog Clin Biol Res. 309:1989;357
2. Winston D.J. Prophylaxis and treatment of infection in the bone marrow transplant recipient. Curr Clin Top Infect Dis. 13:1993;293
3. Meyers J.D., Reed E.C., Shepp D.H., Thornquist M., Dandliker P.S., Vicary C.A., Flournoy N., Kirk L.E., Kersey J.H., Thomas E.D. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med. 318:1988;70
4. Hou S., Hyland L., Ryan K.W., Portner A., Doherty P.C. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature. 369:1994;652
5. Mackenzie C.D., Taylor P.M., Askonas B.A. Rapid recovery of lung histology correlates with clearance of influenza virus by specific CD8+ cytotoxic T cells. Immunology. 67:1989;375
6. Nash A.A., Jayasuriya A., Phelan J., Cobbold S.P., Waldmann H., Prospero T. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol. 68:(Pt 3):1987;825
7. Moskophidis D., Cobbold S.P., Waldmann H., Lehmann-Grube F. Mechanism of recovery from acute virus infection treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J Virol. 61:1987;1867
8. Riddell S.R., Greenberg P.D. Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol. 13:1995;545
9. Reddehase M.J., Mutter W., Munch K., Buhring H.J., Koszinowski U.H. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol. 61:1987;3102
10. Reddehase M.J., Mutter W., Koszinowski U.H. In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection. J Exp Med. 165:1987;650
11. Lucin P., Pavic I., Polic B., Jonjic S., Koszinowski U.H. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol. 66:1992;1977
12. Quinnan G.V. Jr, Kirmani N., Rook A.H., Manischewitz J.F., Jackson L., Moreschi G., Santos G.W., Saral R., Burns W.H. Cytotoxic t cells in cytomegalovirus infection HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med. 307:1982;7
13. Reusser P., Riddell S.R., Meyers J.D., Greenberg P.D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation pattern of recovery and correlation with cytomegalovirus infection and disease. Blood. 78:1991;1373
14. Krause H., Hebart H., Jahn G., Muller C.A., Einsele H. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant. 19:1997;1111
15. Sester M., Sester U., Gartner B., Kubuschok B., Girndt M., Meyerhans A., Kohler H. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol. 76:2002;3748
16. Cwynarski K., Ainsworth J., Cobbold M., Wagner S., Mahendra P., Apperley J., Goldman J., Craddock C., Moss P.A. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood. 97:2001;1232
17. Aubert G., Hassan-Walker A.F., Madrigal J.A., Emery V.C., Morte C., Grace S., Koh M.B., Potter M., Prentice H.G., Dodi I.A., Travers P.J. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. J Infect Dis. 184:2001;955
18. Engstrand M., Lidehall A.K., Totterman T.H., Herrman B., Eriksson B.M., Korsgren O. Cellular responses to cytomegalovirus in immunosuppressed patients circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin Exp Immunol. 132:2003;96
19. Papadopoulos E.B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M.H., Castro-Malaspina H., Childs B.H., Gillio A.P., Small T.N. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med. 330:1994;1185
20. Diamond D.J., York J., Sun J.Y., Wright C.L., Forman S.J. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood. 90:1997;1751
21. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:1992;238
22. Li C.R., Greenberg P.D., Gilbert M.J., Goodrich J.M., Riddell S.R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant correlation with CMV disease and effect of ganciclovir prophylaxis. Blood. 83:1994;1971
23. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med. 333:1995;1038
24. Einsele H., Roosnek E., Rufer N., Sinzger C., Riegler S., Loffler J., Grigoleit U., Moris A., Rammensee H.G., Kanz L., Kleihauer A., Frank F., Jahn G., Hebart H. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood. 99:2002;3916
25. Kleihauer A., Grigoleit U., Hebart H., Moris A., Brossart P., Muhm A., Stevanovic S., Rammensee H.G., Sinzger C., Riegler S., Jahn G., Kanz L., Einsele H. Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells. Br J Haematol. 113:2001;231
26. Peggs K., Verfuerth S., Pizzey A., Ainsworth J., Moss P., Mackinnon S. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood. 99:2002;213
27. Peggs K., Verfuerth S., Pizzey A., Ainsworth J., Moss P., Mackinnon S. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood. 99:2002;213
28. Bissinger A.L., Rauser G., Hebart H., Frank F., Jahn G., Einsele H. Isolation and expansion of human cytomegalovirus-specific cytotoxic T lymphocytes using interferon-gamma secretion assay. Exp Hematol. 30:2002;1178
29. Szmania S., Galloway A., Bruorton M., Musk P., Aubert G., Arthur A., Pyle H., Hensel N., Ta N., Lamb L. Jr, Dodi T., Madrigal A., Barrett J., Henslee-Downey J., van Rhee F. Isolation and expansion of cytomegalovirus- specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood. 98:2001;505
30. Bonini C., Lee S.P., Riddell S.R., Greenberg P.D. Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells. J Immunol. 166:2001;5250
31. Keever-Taylor C.A., Margolis D., Konings S., Sandford G.R., Nicolette C.A., Lawendowski C., Burns W.H. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells. Biol Blood Marrow Transplant. 7:2001;247
32. Hamel Y., Blake N., Gabrielsson S., Haigh T., Jooss K., Martinache C., Caillat-Zucman S., Rickinson A.B., Hacein-Bey S., Fischer A., Cavazzana-Calvo M. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein a novel approach for immunotherapy. Hum Gene Ther. 13:2002;855
33. Kondo E., Topp M.S., Kiem H.P., Obata Y., Morishima Y., Kuzushima K., Tanimoto M., Harada M., Takahashi T., Akatsuka Y. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J Immunol. 169:2002;2164
34. Savoldo B., Cubbage M.L., Durett A.G., Goss J., Huls M.H., Liu Z., Teresita L., Gee A.P., Ling P.D., Brenner M.K., Heslop H.E., Rooney C.M. Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals. J Immunol. 168:2002;909
35. Berencsi K., Gyulai Z., Gonczol E., Pincus S., Cox W.I., Michelson S., Kari L., Meric C., Cadoz M., Zahradnik J., Starr S., Plotkin S. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. J Infect Dis. 183:2001;1171
36. Bonini C., Ferrari G., Verzeletti S., Servida P., Zappone E., Ruggieri L., Ponzoni M., Rossini S., Mavilio F., Traversari C., Bordignon C. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 276:1997;1719
37. Riddell S.R., Elliott M., Lewinsohn D.A., Gilbert M.J., Wilson L., Manley S.A., Lupton S.D., Overell R.W., Reynolds T.C., Corey L., Greenberg P.D. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med. 2:1996;216
38. Riddell S.R., Greenberg P.D., Overell R.W., Loughran T.P., Gilbert M.J., Lupton S.D., Agosti J., Scheeler S., Coombs R.W., Corey L. Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology. Hum Gene Ther. 3:1992;319
39. Sauce D., Bodinier M., Garin M., Petracca B., Tonnelier N., Duperrier A., Melo J.V., Apperley J.F., Ferrand C., Herve P., Lang F., Tiberghien P., Robinet E. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood. 99:2002;1165
40. Cooper L.J., Kalos M., Lewinsohn D.A., Riddell S.R., Greenberg P.D. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J Virol. 74:2000;8207
41. Kessels H.W., van D.B., Spits H., Hooijberg E., Schumacher T.N. Changing T cell specificity by retroviral T cell receptor display. Proc Natl Acad Sci U S A. 97:2000;14578
42. Orentas R.J., Roskopf S.J., Nolan G.P., Nishimura M.I. Retroviral transduction of a T cell receptor specific for an Epstein-Barr virus-encoded peptide. Clin Immunol. 98:2001;220
43. Rossig C., Bollard C.M., Nuchtern J.G., Rooney C.M., Brenner M.K. Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors potential for improved immunotherapy. Blood. 99:2002;2009